As of January 22, 2025, Aadi Bioscience (AADI) has a market cap of $73.795 million USD. According to our data, Aadi Bioscience is ranked No.7921 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $73.80 M |
-5.23%
|
Dec 31, 2024 | $77.87 M |
56.19%
|
Dec 29, 2023 | $49.86 M |
-84.26%
|
Dec 30, 2022 | $0.32 B |
-46.87%
|
Dec 31, 2021 | $0.60 B |
64.29%
|
Dec 31, 2020 | $0.36 B |
57.05%
|
Dec 31, 2019 | $0.23 B |
-63.29%
|
Dec 31, 2018 | $0.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
Verastem Oncology
VSTM
|
$0.25 B |
-0.000 M
|
USA
|
OncoCyte
OCX
|
$33.00 M |
0.000 M
|
USA
|
Market Cap | = | AADI Stock Price | * | AADI Shares Outstanding |
= | $2.99 | * | 24.68 M | |
= | $73.80 M |